Delaware
|
0-23047
|
13-3864870
|
(State or other jurisdiction of incorporation or organization)
|
(Commission file number)
|
(I.R.S. employer identification no.)
|
660 Madison Avenue, Suite 1700
New York, New York
(Address of principal executive offices)
|
10065
(Zip code)
|
r | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
r | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
r | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
r | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
·
|
On December 23, 2015, SIGA Technologies, Inc., a Delaware corporation (“SIGA”), issued a press release announcing the decision of the Delaware Supreme Court affirming the prior Court of Chancery Opinion in which the Court of Chancery awarded PharmAthene, Inc. approximately $195 million, including pre-judgment interest up to January 15, 2015.
|
Exhibit No.
|
Description
|
|
Press Release, dated December 23, 2015.
|
SIGA TECHNOLOGIES, INC.
|
||
By:
|
/s/ Daniel J. Luckshire
|
|
Name:
|
Daniel J. Luckshire
|
|
Title:
|
Chief Financial Officer
|